<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Using flow chamber system, we quantitatively studied the <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> of erythrocytes (RBCs) of patients with <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> (CTh) to cultured human umbilical vein endothelial cells (HUVECs) treated with <z:chebi fb="0" ids="30492">H2O2</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>The results showed that injured HUVECs enhanced <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> of RBCs to HUVECs in patients with CTh </plain></SENT>
<SENT sid="2" pm="."><plain>There is injury of endothelial cells in the pathogenetic and pathologic process of CTh, and the <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> of RBCs to ECs promotes vaso-occlusive and vascular damage; thus the <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> of RBCs to injured ECs might play an important role in the pathogenesis and pathologic process of CTh </plain></SENT>
</text></document>